Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Multiple Sclerosis Society of Canada's MS Scientific Research Foundation
ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study): A Randomized, Double-Blind, Placebo-Controlled Trial.
Papers: 30 May 2014 - 6 Jun 2014
MS Genetics: The Outer Limits
Eyeing Neurodegeneration
Pathological Anatomy: Illustrations of the elementary forms of disease.
Fuel Injection
Keystone Symposia Conference: Neuroinflammation in Diseases of the Central Nervous System
PrecisionMed
Multiple Sklerose und Erbanlage
Lower Risk of MS in People With HIV
FDA Approves Alemtuzumab for MS
Episode 82 with Dr. Adam Kaplin on depression & MS
Postdoctoral position in research on myelination
Papers: 9 May 2014 - 16 May 2014
PPMS: Predictors of Disease Progression Still Unknown
Guthy-Jackson Charitable Foundation
Papers: 3 Oct 2014 - 10 Oct 2014
MS Research Roundup: February 20, 2014
Peripheral B Cell Activation May Drive CNS Autoimmunity in MS
Papers: 2 Apr 2012 - 9 Apr 2012
MS Patient, Ph.D.: Home From the Hospital
IL-1β Levels During MS Remission May Predict Progression
MS Trial Alert
National Institutes of Health

Pages

« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By